Breaking News, Financial News

Financial Report: Allergan 4Q

Specialty pharmaceuticals sales were up 18% to $995 million in the quarter, and for the year sales were up 5% to $3.7 billion.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Allergan 4Q 4Q Revenues: $1.2 billion (+16%) 4Q Earnings: $221.5 million (+51%) FY Revenues: $4.5 billion (+2%) FY Earnings: $621.3 million (+10%) Comments: Specialty pharmaceuticals sales were up 18% to $995 million in the quarter, and for the year sales were up 5% to $3.7 billion. Eye care pharmaceutical sales increased 21% in the quarter driven by Alphagan and Combigan franchises and Lumigan and Restasis sales....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters